What will I learn?
Research within the Drug Design and Delivery research group aims to design and analyse new drugs, and to develop new formulations and characterisation tools towards the delivery and targeting of therapeutic agents in the treatment of inflammatory diseases, cancers, infections, asthma, diabetes and CNS conditions. In addition to progressing in-house molecules, the translational thrust of the group is effective in collaborative and fee-for-service research.Our members are international leaders in their field, undertaking collaborative research with leading Pharma companies and SMEs, and our work has resulted in a number of patents. We receive UK grants to work with experts in industry who have experience of synthesis and development.Research in drug discovery involves the chemical synthesis and biological evaluation of compounds and pro-drugs that have potential anticancer and antibacterial properties, as well as the development of new synthetic methods to make such compounds, prodrugs and nano-composites.Strong formulation activity is built around nano-formulation, biopharmaceutical challenges, aspects of solubilization, and the developmental area of clinical pharmaceutics investigating drug/drug and drug/excipient interaction. We also have experience in the delivery of drugs to the lung.
Which department am I in?
University of Central Lancashire
Entry requirements
For international students
A recognised UK first degree, second class honours or above or equivalent qualification.Where English is not your first language an English language qualification is required at IELTS 6.5/7.0 or equivalent, acceptable qualification.
Help me Apply
